Protein A Resin Market Predicted to Grow Beyond $1,000.0 Million Value by 2030

In 2019, the global protein A resin market reached a valuation of $486.4 million in 2019 and is predicted to generate a revenue of $1,020.7 million by 2030.

As per the market research company, P&S Intelligence, the market will advance at a CAGR of 7.0% between 2019 and 2030. The rising incidence of chronic diseases, the surging geriatric population, and the soaring investments being made for protein-based research are the main factors fueling the expansion of the market.

Several private and public organizations and institutes are making huge investments in protein-based research programs for improving therapeutic procedures. For example, the National Institute of Health (NIH), which is a healthcare research center based in the U.S., makes an investment of around $32.3 million in medical research every year. The organization provides grants to the various research projects and programs being carried out in the medical and life sciences fields. 

Access Detailed Report on Protein A Resin Market Regional and Country Breakdown

Furthermore, several leading players in the pharmaceutical and biotechnology industries such as Merck & Co. Inc. and Thermo Fisher Scientific Inc. are investing heavily in research and development (R&D) projects in the domain of protein-based research. The surging population of geriatric people is another important factor propelling the advancement of the global market. As per the United Nations Population Fund, people in the age bracket- 60 years or above account for as much as 12.3% of the global population currently. 

Between these, the recombinant category recorded higher growth in the market during the last few years. This was because of the rising requirement for recombinants in antibody purification processes. The protein a resin market is also classified, on the basis of end user, into biotechnology and pharmaceutical industries and academic institutes and research laboratories. Of these, the biotechnology and pharmaceutical industries registered higher growth in the market in the past years.

Thus, it is safe to say that the market will exhibit huge expansion all over the world in the future years, mainly because of the rising incidence of chronic diseases, the mushrooming population of geriatric people, and the soaring investments being made in R&D projects in the domain of protein-based research.